Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer
This study has been completed.
Study NCT00079612   Information provided by Bayer
First Received: March 9, 2004   Last Updated: June 4, 2009   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given